Haemonetics Acquires Attune Medical
March 5, 2024
Haemonetics Corporation has agreed to acquire privately-held Attune Medical, the maker of the FDA-cleared ensoETM esophageal cooling device, for $160 million upfront plus contingent consideration. The acquisition will expand Haemonetics' electrophysiology and temperature-management capabilities and is expected to close in Haemonetics' fiscal 2025 first quarter.
- Buyers
- Haemonetics Corporation
- Targets
- Attune Medical
- Industry
- Medical Devices
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Haemonetics Corporation Acquires OpSens Inc.
December 12, 2023
Medical Devices
Haemonetics Corporation completed its acquisition of OpSens Inc. in an all-cash transaction for CAD $2.90 per share, representing a fully diluted equity value of approximately USD $255 million. The deal expands Haemonetics' hospital/interventional cardiology portfolio with OpSens' fiber-optic sensor technology (including the SavvyWire and OptoWire); OpSens will be delisted and Haemonetics expects OpSens to contribute $55–$65 million in revenue in fiscal 2025.
-
Haemonetics Acquires Cardiva Medical
January 20, 2021
Medical Devices
Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.
-
Haemonetics Acquires Vivasure Medical
January 11, 2026
Medical Devices
Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.
-
Integration Health Acquires ECMO Advantage
September 18, 2025
Healthcare Services
Integration Health has acquired ECMO Advantage, combining two leading ECMO, perfusion, and transplant support providers to create a unified national platform. The combined organization will serve over 55 hospitals across 22 states, expanding specialized clinical staffing, program development, transport, and education services for ECMO and perfusion care.
-
AMETEK Acquires Paragon Medical from American Securities for ~$1.9B
October 31, 2023
Medical Devices
AMETEK, Inc. has agreed to acquire Paragon Medical, a Pierceton, Indiana-based contract manufacturer of medical components and instruments, from private equity firm American Securities in an all-cash transaction valued at approximately $1.9 billion. The deal advances AMETEK’s capabilities and footprint in medical device manufacturing and is subject to customary closing conditions and regulatory approvals.
-
ESAB Corporation Acquires Ohio Medical
October 17, 2022
Medical Devices
ESAB Corporation (NYSE: ESAB) acquired Ohio Medical, LLC, a manufacturer of oxygen regulators and central gas systems, for $127 million in cash. The acquisition, purchased from a private investor group led by Tenex Capital Management, expands ESAB's medical gas control portfolio and is expected to be EPS accretive in the first year while providing cross-selling and global expansion opportunities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.